1.in Article 1, paragraph 2 is amended as follows:
(a)in point (b), ‘EUR 5000000’ is replaced by ‘EUR 3600000’;
(b)points (e) and (f) are replaced by the following:
(e)EUR 1200000 for Portugal;
(f)EUR 1700000 for the United Kingdom.’;
10.in Article 10, paragraphs 2 and 3 are replaced by the following:‘2.The financial contribution by the Union shall be at the rate of 75 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests for the detection of rabies antigen or antibodies, the isolation and characterisation of the rabies virus, the detection of biomarker and the titration of vaccine baits, and for the purchase and distribution of vaccine plus baits for the programmes, and shall not exceed:
(a)EUR 1870000 for Bulgaria;
(a)for a serological test: EUR 12 per test;
(b)EUR 680000 for Hungary;
(b)for a test to detect tetracycline in bone: EUR 12 per test;
(c)EUR 7380000 for Poland;
(c)for a fluorescent antibody test (FAT): EUR 18 per test.’;
(d)EUR 820000 for Romania;
(e)EUR 490000 for Slovakia.
3.The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:
11.in Article 11, paragraph 2 is amended as follows:
(a)in point (b), ‘EUR 20000’ is replaced by ‘EUR 40000’;
(b)in point (d), ‘EUR 1400000’ is replaced by ‘EUR 650000’;
12.in Article 12, paragraph 2 is replaced by the following:‘2.The financial contribution by the Union to the programmes referred to in paragraph 1 shall be at the rate of 50 % of the costs to be incurred by the concerned Member State for the cost of laboratory tests, and shall not exceed:
(a)EUR 25000 for Bulgaria;
(b)EUR 300000 for Hungary;
(c)EUR 1000000 for Poland;
(d)EUR 700000 for Spain.’;
13.in Article 13, paragraphs 3 and 4 are replaced by the following:‘3.The financial contribution by the Union shall be at the rate of 75 % of the costs to be incurred by each Member State referred to in paragraphs 1 and 2 for the cost of carrying out laboratory tests for the detection of rabies antigen or antibodies, the characterisation of the rabies virus, the detection of biomarker, age determination and the titration of vaccine baits, and for the purchase and distribution of vaccine plus baits for the programmes, and shall not exceed:
(a)EUR 1360000 for Estonia;
(a)for a serological test: EUR 12 per test;
(b)EUR 1400000 for Latvia;
(b)for a test to detect tetracycline in bone: EUR 12 per test;
(c)EUR 540000 for Lithuania;
(c)for a fluorescent antibody test (FAT): EUR 18 per test.’;
(d)EUR 200000 for Austria;
(e)EUR 830000 for Slovenia;
(f)EUR 150000 for Finland.
4.The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraphs 1 and 2 shall on average not exceed:
14.in Article 14(2), ‘EUR 262000’ is replaced by ‘EUR 310000’;
15.in Article 15, paragraph 2 is amended as follows:
(a)in point (a) ‘EUR 800000’ is replaced by ‘EUR 600000’;
(b)in point (c) ‘EUR 750000’ is replaced by ‘EUR 500000’;
16.in Article 16(2), in the introductory phrase, ‘EUR 8200000’ is replaced by ‘EUR 4000000’.
2.in Article 2, paragraph 2 is replaced by the following:‘2.The financial contribution by the Union shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the costs of carrying out tuberculin and laboratory tests and the compensation to owners for the value of their animals slaughtered subject to those programmes, and shall not exceed:
4.in Article 4, paragraph 2 is amended as follows:
(a)in point (c), ‘EUR 1600000’ is replaced by ‘EUR 1650000’;
(b)in point (e), ‘EUR 16800000’ is replaced by ‘EUR 1700000’;
(c)points (i) and (j) are replaced by the following:
(i)EUR 19000000 for Spain;
(j)EUR 33500000 for France;’;
(d)points (l) and (m) are replaced by the following:
(l)EUR 20000 for Latvia;
(m)EUR 10000 for Lithuania;’;
(e)in point (o), ‘EUR 780000’ is replaced by ‘EUR 70000’;
(f)in point (q), ‘EUR 110000’ is replaced by ‘EUR 130000’;
(g)in point (t), ‘EUR 5200000’ is replaced by ‘EUR 2100000’;
(h)in point (v), ‘EUR 590000’ is replaced by ‘EUR 40000’;
(i)points (x) and (y) are replaced by the following:
(x)EUR 20000 for Finland;
(y)EUR 850000 for Sweden.’;
5.in Article 5, paragraph 2 is amended as follows:
(a)in point (a), ‘EUR 2000000’ is replaced by ‘EUR 900000’;
(b)points (d) and (e) are replaced by the following:
(d)EUR 400000 for Denmark;
(e)EUR 25000 for Estonia;’;
(c)in point (i), ‘EUR 2500000’ is replaced by ‘EUR 1400000’;
(d)in point (k), ‘EUR 1250000’ is replaced by ‘EUR 900000’;
(e)points (m) and (n) are replaced by the following:
(m)EUR 50000 for Latvia;
(n)EUR 10000 for Lithuania;’;
(f)points (t) and (u) are replaced by the following:
(t)EUR 4600000 for Poland;
(u)EUR 55000 for Portugal;’;
(g)points (x) and (y) are replaced by the following:
(x)EUR 600000 for Slovakia;
(y)EUR 80000 for the United Kingdom.’;
6.in Article 6, paragraph 2 is amended as follows:
(a)in point (a), ‘EUR 240000’ is replaced by ‘EUR 120000’;
(b)in point (f), ‘EUR 300000’ is replaced by ‘EUR 550000’;
(c)in point (i), ‘EUR 515000’ is replaced by ‘EUR 250000’;
7.in Article 7(2), ‘EUR 450000’ is replaced by ‘EUR 250000’;
8.in Article 8, paragraph 2 is amended as follows:
(a)in point (e), ‘EUR 350000’ is replaced by ‘EUR 450000’;
(b)in point (k), ‘EUR 650000’ is replaced by ‘EUR 1300000’;
(c)in point (t), ‘EUR 200000’ is replaced by ‘EUR 40000’;
9.Article 9 is amended as follows:
(a)paragraph 2 is replaced by the following:‘2.The financial contribution by the Union shall be at the rate of 100 % of the costs to be incurred by each Member State referred to in paragraph 1 for carrying out rapid tests in animals as referred to in Article 12 paragraph 2 of Regulation (EC) No 999/2001, Annex III Chapter A Parts I and II points 1 to 5 of Regulation (EC) No 999/2001 and Annex VII to that Regulation, confirmatory tests and primary molecular discriminatory tests as referred to in of Annex X Chapter C point 3(2)(c)(i) of Regulation (EC) No 999/2001 and at the rate of 50 % of the cost incurred by each Member State for the compensation to owners for the value of their animals culled and destroyed in accordance with their BSE and scrapie eradication programmes and at a rate of 50 % of the cost of the analysis of samples for genotyping, and shall not exceed:
(a)EUR 2340000 for Belgium;
(b)EUR 440000 for Bulgaria;
(c)EUR 1380000 for the Czech Republic;
(d)EUR 1420000 for Denmark;
(e)EUR 11260000 for Germany;
(f)EUR 300000 for Estonia;
(g)EUR 4700000 for Ireland;
(h)EUR 2000000 for Greece;
(i)EUR 6480000 for Spain;
(j)EUR 16980000 for France;
(k)EUR 7210000 for Italy;
(l)EUR 70000 for Cyprus;
(m)EUR 360000 for Latvia;
(n)EUR 700000 for Lithuania;
(o)EUR 100000 for Luxembourg;
(p)EUR 1230000 for Hungary;
(q)EUR 30000 for Malta;
(r)EUR 3370000 for the Netherlands;
(s)EUR 1510000 for Austria;
(t)EUR 4930000 for Poland;
(u)EUR 1640000 for Portugal;
(v)EUR 1000000 for Romania;
(w)EUR 240000 for Slovenia;
(x)EUR 650000 for Slovakia;
(y)EUR 610000 for Finland;
(z)EUR 970000 for Sweden;
(za)EUR 5920000 for the United Kingdom.’;
(b)in paragraph 3, in point (a), ‘EUR 5 per test’ is replaced by ‘EUR 8 per test’;